OsciFlex LLC was founded in 2017 by John Welsh, PhD and Mark Kahn, MD at the University of Pennsylvania. Dr. Welsh and Dr. Kahn discovered the molecular pathways relating blood flow pattern to endothelial gene expression of thrombosis related proteins, outlined a protocol to analyze venous valve oscillatory flow in human subjects using vascular ultrasound, and created the initial OsciFlex device design.